Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Booth

Showing results (851-860 of 874) with videos related to

Pageof 88
Sort By:
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Nature Biotechnology|February 4, 2026
Pilot phase clinical trial of a wearable, electrochemical aptamer-based patch for continuous drug concentration measurementMarsilea A Booth, Murat K Erdal, Mikel Larson, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
NPJ Vaccines|December 22, 2017
<i>In vivo</i> protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccineKaruppiah Muthumani, Bryan D Griffin, Sangya Agarwal, et al.
Brain : a Journal of Neurology|February 7, 2025
De novo and inherited variants in DDX39B cause a novel neurodevelopmental syndromeKevin T A Booth, Sharayu V Jangam, Martin M C Chui, et al.
Nature Communications|June 8, 2017
DNA vaccination protects mice against Zika virus-induced damage to the testesBryan D Griffin, Kar Muthumani, Bryce M Warner, et al.
Journal of the American Heart Association|June 16, 2017
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failureFrancine Z Marques, Priscilla R Prestes, Sean G Byars, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 9, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
The Canadian Journal of Cardiology|May 16, 2024
Assay Precision and Risk of Misclassification at Rule-Out Cutoffs for High-Sensitivity Cardiac TroponinPeter A Kavsak, Nicholas L Mills, Lorna Clark, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 23, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
Pageof 88

Showing results (851-860 of 874) with videos related to

Sort By:
Pageof 88
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Nature Biotechnology|February 4, 2026
Pilot phase clinical trial of a wearable, electrochemical aptamer-based patch for continuous drug concentration measurementMarsilea A Booth, Murat K Erdal, Mikel Larson, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
NPJ Vaccines|December 22, 2017
<i>In vivo</i> protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccineKaruppiah Muthumani, Bryan D Griffin, Sangya Agarwal, et al.
Brain : a Journal of Neurology|February 7, 2025
De novo and inherited variants in DDX39B cause a novel neurodevelopmental syndromeKevin T A Booth, Sharayu V Jangam, Martin M C Chui, et al.
Nature Communications|June 8, 2017
DNA vaccination protects mice against Zika virus-induced damage to the testesBryan D Griffin, Kar Muthumani, Bryce M Warner, et al.
Journal of the American Heart Association|June 16, 2017
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failureFrancine Z Marques, Priscilla R Prestes, Sean G Byars, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 9, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
The Canadian Journal of Cardiology|May 16, 2024
Assay Precision and Risk of Misclassification at Rule-Out Cutoffs for High-Sensitivity Cardiac TroponinPeter A Kavsak, Nicholas L Mills, Lorna Clark, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 23, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
Pageof 88